Argent Trust Co lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 26,439 shares of the healthcare conglomerate’s stock after selling 159 shares during the period. Argent Trust Co’s holdings in UnitedHealth Group were worth $9,837,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of UNH. OLD Mission Capital LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth $439,000. Sage Mountain Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth $463,000. Eagle Capital Management LLC increased its holdings in shares of UnitedHealth Group by 1.0% in the fourth quarter. Eagle Capital Management LLC now owns 16,018 shares of the healthcare conglomerate’s stock worth $5,617,000 after purchasing an additional 152 shares during the period. Camden National Bank increased its holdings in shares of UnitedHealth Group by 5.5% in the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock worth $667,000 after purchasing an additional 100 shares during the period. Finally, Almanack Investment Partners LLC. increased its holdings in shares of UnitedHealth Group by 21.9% in the fourth quarter. Almanack Investment Partners LLC. now owns 2,115 shares of the healthcare conglomerate’s stock worth $742,000 after purchasing an additional 380 shares during the period. Hedge funds and other institutional investors own 86.23% of the company’s stock.
In other news, EVP Patricia L. Lewis sold 3,000 shares of UnitedHealth Group stock in a transaction on Friday, April 16th. The shares were sold at an average price of $389.99, for a total transaction of $1,169,970.00. Following the transaction, the executive vice president now owns 9,214 shares in the company, valued at approximately $3,593,367.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction on Monday, April 19th. The stock was sold at an average price of $391.25, for a total transaction of $978,125.00. Following the transaction, the director now owns 154,181 shares in the company, valued at approximately $60,323,316.25. The disclosure for this sale can be found here. Insiders have sold 14,801 shares of company stock valued at $5,653,468 in the last three months. 0.80% of the stock is owned by insiders.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $4.38 by $0.93. UnitedHealth Group had a net margin of 6.42% and a return on equity of 26.04%. The company had revenue of $70.20 billion during the quarter, compared to analyst estimates of $69.13 billion. During the same period in the prior year, the business posted $3.72 earnings per share. UnitedHealth Group’s revenue for the quarter was up 9.0% on a year-over-year basis. On average, analysts predict that UnitedHealth Group Incorporated will post 18.55 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 29th. Investors of record on Monday, June 21st will be given a dividend of $1.45 per share. The ex-dividend date is Friday, June 18th. This represents a $5.80 annualized dividend and a dividend yield of 1.46%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.25. UnitedHealth Group’s dividend payout ratio (DPR) is 29.62%.
UNH has been the topic of several research analyst reports. BMO Capital Markets upped their price target on shares of UnitedHealth Group from $410.00 to $435.00 and gave the stock a “market perform” rating in a report on Friday, April 16th. Oppenheimer increased their target price on UnitedHealth Group from $375.00 to $440.00 and gave the company an “outperform” rating in a research note on Friday, April 16th. Mizuho increased their target price on UnitedHealth Group from $394.00 to $455.00 and gave the company a “buy” rating in a research note on Friday, May 7th. Wells Fargo & Company began coverage on UnitedHealth Group in a research note on Monday, May 24th. They issued an “overweight” rating and a $478.00 target price on the stock. Finally, Morgan Stanley increased their target price on UnitedHealth Group from $462.00 to $515.00 and gave the company an “overweight” rating in a research note on Friday, April 16th. Three investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $425.14.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Featured Story: The Structure of a Futures Contract
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.